2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
20
Carcinoma, Non-Small-Cell Lung
20
Uterine Cervical Neoplasms
15
Oropharyngeal Neoplasms
14
Lung Neoplasms
14
Mouth Neoplasms
10
Laryngeal Neoplasms
10
Carcinoma
10
Urinary Bladder Neoplasms
8
Hypopharyngeal Neoplasms
8
Cholangiocarcinoma
8
Pancreatic Neoplasms
7
Ovarian Neoplasms
7
Nasopharyngeal Carcinoma
6
Mesothelioma, Malignant
6
Medulloblastoma
6
Gallbladder Neoplasms
6
Neuroblastoma
5
Ganglioneuroblastoma
5
Fallopian Tube Neoplasms
5
Lymphoid Interstitial Pneumonia
4
Vulvar Neoplasms
3
Urethral Neoplasms
3
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Carcinoma, Transitional Cell
3
Brenner Tumor
3
Adenocarcinoma of Lung
3
Vaginal Neoplasms
2
Interventions
Fluorouracil
9
Radiotherapy
7
Cisplatin
7
Radiotherapy, Intensity-Modulated
4
Mitomycin
4
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
Radiation
3
Nivolumab
3
Capecitabine
3
dehydroftorafur
2
Taxes
2
Paclitaxel
2
Cetuximab
2
Carboplatin
2
Biopsy
2
toripalimab
1
rocakinogene sifuplasmid
1
pembrolizumab
1
durvalumab
1
atezolizumab
1
X-Rays
1
Watchful Waiting
1
Vaccines
1
VGX-3100
1
Sigmoidoscopy
1
Radiosurgery
1
Proctoscopy
1
Platinum
1
Phantoms, Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anal Canal Carcinoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
NCT02560298
2023-06-22
InterAACT
Eastern Cooperative Oncology Group
Phase 2
Unknown
91 enrolled